Difficulties in Describing Allergic Disease Modulation by Pre-, Pro- and Synbiotics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|16|2369-2374

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.16, 2012-06, pp. : 2369-2374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of the Maturing Gut Barrier and Microbiota: A Novel Target in Allergic Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 14, 2008-01 ,pp. : 1368-1375

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokine Modulation for Anti-Allergic Treatment

By  

Current Pharmaceutical Design, Vol. 8, Iss. 20, 2002-09 ,pp. : 1845-1853

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy approach to allergic disease

By Fick R.B.   Fox J.A.   Jardieu P.M.  

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 307-310

Elsevier

Access to resources Recommend Favorite

Immunotherapeutic Targeting of Allergic Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 4, 2006-12 ,pp. : 243-252

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokine modulation reduces eosinophilia in allergic asthma

By  

Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite